JAMIE MOSBRUCKER: Open Payments
NPI 1669822201 · CASPER, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,420 in 61 payments from 14 companies in 2025. Trend: 2023 $906 · 2024 $1,407 · 2025 $1,420
Food & beverage: $1,420
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $417 |
| ABBVIE INC. | 18 | $318 |
| Phathom Pharmaceuticals, Inc. | 4 | $110 |
| Madrigal Pharmaceuticals | 4 | $94 |
| Enterra Medical, Inc. | 1 | $78 |
| Aimmune Therapeutics, Inc. | 4 | $73 |
| Janssen Biotech, Inc. | 3 | $65 |
| Regeneron Healthcare Solutions, Inc. | 3 | $64 |
| Gilead Sciences, Inc. | 2 | $49 |
| PFIZER INC. | 3 | $47 |
Products named: ENTYVIO, LINZESS, EOHILIA, VOQUEZNA, DUPIXENT, REZDIFFRA, RINVOQ, ZENPEP.
Industry payments across WY — which companies pay providers there.
